Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	16.67	18.67	19.81	15.82	7.53	4.09
Research & Development	18.01	18.3	30.38	21.66	11.19	8.35
Operating Expenses	34.69	36.96	50.19	37.48	18.71	12.44
Operating Income	-34.69	-36.96	-50.19	-37.48	-18.71	-12.44
Interest Expense	-0.13	-0.14	-0.22	-0.67	-1.69	-2.26
Interest & Investment Income	3.42	3.62	1.78	0.8	-	-
Other Non Operating Income (Expenses)	-1.04	-1.27	0.25	0.61	1	-1.97
EBT Excluding Unusual Items	-32.43	-34.76	-48.37	-36.75	-19.41	-16.67
Merger & Restructuring Charges	-0.1	-0.1	-	-	-	-
Gain (Loss) on Sale of Investments	0.82	1.06	-0.22	-0.62	-	-
Gain (Loss) on Sale of Assets	-0.21	-0.3	-	-	-	-
Other Unusual Items	-	-	-	0.57	0.05	-0.08
Pretax Income	-31.92	-34.1	-48.59	-36.79	-20.1	-16.74
Earnings From Continuing Operations	-	-34.1	-48.59	-36.79	-20.1	-16.74
Net Income	-31.92	-34.1	-48.59	-36.79	-20.1	-16.74
Preferred Dividends & Other Adjustments	-	-	-	-	0.1	3.8
Net Income to Common	-31.92	-34.1	-48.59	-36.79	-20.2	-20.54
Shares Outstanding (Basic)	26	28	31	28	2	0
Shares Outstanding (Diluted)	26	28	31	28	2	0
Shares Change (YoY)	-13.85%	-8.96%	10.80%	1618.88%	338.85%	0.02%
EPS (Basic)	-1.20	-1.22	-1.58	-1.33	-12.53	-55.92
EPS (Diluted)	-1.20	-1.22	-1.58	-1.33	-12.53	-55.92
Free Cash Flow	-27.97	-32.2	-39.35	-32.29	-18.91	-8.62
Free Cash Flow Per Share	-1.06	-1.15	-1.28	-1.17	-11.73	-23.48
EBITDA	-33.36	-35.61	-48.84	-36.8	-18.5	-12.36
D&A For EBITDA	1.32	1.35	1.35	0.69	0.21	0.07
EBIT	-34.69	-36.96	-50.19	-37.48	-18.71	-12.44

Source: S&P Capital IQ. Standard template.